Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pollak

Showing results (81-90 of 236) with videos related to

Pageof 24
Sort By:
Gynecologic Oncology|June 28, 2014
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancerIdo Laskov, Laura Drudi, Marie-Claude Beauchamp, et al.
Journal of the National Cancer Institute|April 8, 2004
A prospective study of plasma C-peptide and colorectal cancer risk in menJing Ma, Edward Giovannucci, Michael Pollak, et al.
American Journal of Epidemiology|September 20, 2008
Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokersRachael Z Stolzenberg-Solomon, Stephanie Weinstein, Michael Pollak, et al.
Neoplasia (New York, N.Y.)|March 30, 2021
Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozinDavid Papadopoli, Oro Uchenunu, Ranveer Palia, et al.
Journal of the National Cancer Institute|July 18, 2002
Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancerJune M Chan, Meir J Stampfer, Jing Ma, et al.
Cancer Causes & Control : CCC|April 27, 2012
A dietary pattern that is associated with C-peptide and risk of colorectal cancer in womenTeresa T Fung, Frank B Hu, Matthias Schulze, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
Nutritional predictors of insulin-like growth factor I and their relationships to cancer in menEdward Giovannucci, Michael Pollak, Yan Liu, et al.
Cancer Research|July 23, 2003
Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish menKaren Woodson, Joseph A Tangrea, Michael Pollak, et al.
BMC Endocrine Disorders|June 11, 2020
Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic reviewJuan Gómez-Izquierdo, Kristian B Filion, Jean-Franҫois Boivin, et al.
Diabetes Care|November 11, 2021
Clinically Relevant Circulating Protein Biomarkers for Type 1 Diabetes: Evidence From a Two-Sample Mendelian Randomization StudyNahid Yazdanpanah, Mojgan Yazdanpanah, Ye Wang, et al.
Pageof 24

Showing results (81-90 of 236) with videos related to

Sort By:
Pageof 24
Gynecologic Oncology|June 28, 2014
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancerIdo Laskov, Laura Drudi, Marie-Claude Beauchamp, et al.
Journal of the National Cancer Institute|April 8, 2004
A prospective study of plasma C-peptide and colorectal cancer risk in menJing Ma, Edward Giovannucci, Michael Pollak, et al.
American Journal of Epidemiology|September 20, 2008
Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokersRachael Z Stolzenberg-Solomon, Stephanie Weinstein, Michael Pollak, et al.
Neoplasia (New York, N.Y.)|March 30, 2021
Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozinDavid Papadopoli, Oro Uchenunu, Ranveer Palia, et al.
Journal of the National Cancer Institute|July 18, 2002
Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancerJune M Chan, Meir J Stampfer, Jing Ma, et al.
Cancer Causes & Control : CCC|April 27, 2012
A dietary pattern that is associated with C-peptide and risk of colorectal cancer in womenTeresa T Fung, Frank B Hu, Matthias Schulze, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
Nutritional predictors of insulin-like growth factor I and their relationships to cancer in menEdward Giovannucci, Michael Pollak, Yan Liu, et al.
Cancer Research|July 23, 2003
Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish menKaren Woodson, Joseph A Tangrea, Michael Pollak, et al.
BMC Endocrine Disorders|June 11, 2020
Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic reviewJuan Gómez-Izquierdo, Kristian B Filion, Jean-Franҫois Boivin, et al.
Diabetes Care|November 11, 2021
Clinically Relevant Circulating Protein Biomarkers for Type 1 Diabetes: Evidence From a Two-Sample Mendelian Randomization StudyNahid Yazdanpanah, Mojgan Yazdanpanah, Ye Wang, et al.
Pageof 24